Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
Melanotan II
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Sexual & Aesthetics › Melanotan II
← Back to catalog Sexual & AestheticsAvailable

Melanotan II (10 mg)

MelanocortinTanningα-MSH
$59 USD10 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Synthetic α-MSH analog — activates melanocortin receptors (MC1R/MC4R) — research areas: melanogenesis, energy balance, sexual signaling.

  • Mechanism: α-MSH analog on melanocortin receptors (MC1R/MC4R); stimulates melanogenesis.
  • Evidence: Limited human data; mostly research and anecdotal use.
  • In context: Darkens moles/skin — watch for new or changing moles (melanoma caution); gray-market sources often mislabel it.
Research range · SC
250–500 mcg per application · daily while loading, then 1–2×/week
🔴 Research convention · never approved; safety reports

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundMelanotan II
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC50H69N15O9
Molecular weight1024.18 g/mol
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

Melanotan II: research profile

Melanotan II is a synthetic cyclic heptapeptide — Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 — designed in the 1980s at the University of Arizona by Victor Hruby's and Mac Hadley's groups as a superpotent, stable analog of α-melanocyte-stimulating hormone (α-MSH). The ring formed by a lactam bond between aspartate and lysine, together with the D-phenylalanine, gives it peptidase resistance and melanocortin-receptor affinity far above those of the natural hormone.

It is a non-selective agonist: it activates MC1R on melanocytes, responsible for eumelanin synthesis and the darkening of skin and moles, but also MC3R and MC4R in the central nervous system, involved in appetite, erectile function and nausea. It was precisely in early Melanotan II trials as a tanning agent that spontaneous erections were observed, a finding that led to the development of PT-141 (bremelanotide), its MC4R-selective metabolite.

It never completed clinical development and is not approved in any country; the molecule that did reach approval via MC1R is afamelanotide (Scenesse), a linear analog indicated for erythropoietic protoporphyria. Regulatory agencies in several countries have issued warnings about Melanotan II over published cases of melanoma, darkening and changing moles, rhabdomyolysis and priapism, and over how often grey-market product is mislabeled. Renova distributes it for research only.

Melanotan II technical data

ClassSynthetic cyclic α-MSH analog, non-selective melanocortin agonist
SequenceAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 (7 aa; Asp–Lys lactam bridge)
CAS121062-08-6
OriginUniversity of Arizona (Hruby, Hadley), 1980s
ReceptorsMC1R (pigmentation), MC3R and MC4R (CNS: appetite, erectile function, nausea), MC5R
Relation to PT-141Bremelanotide is its free-C-terminus metabolite, MC4R-selective
Regulatory statusNever approved; regulatory-agency warnings; the approved MC1R analog is afamelanotide (Scenesse)
Published safety signalsDarkening and changing moles, melanoma (case reports), nausea, rhabdomyolysis, priapism

Questions about Melanotan II

What is the difference between Melanotan II and PT-141?

PT-141 (bremelanotide) is the metabolite of Melanotan II with a free carboxyl terminus instead of the amide. That minimal change makes it MC4R-selective and strips away almost all of MC1R's pigmentary action. Melanotan II activates both: it tans and acts in the central nervous system at the same time.

Why does Melanotan II darken moles?

Because the MC1R receptor it stimulates is on every melanocyte, including those in nevi. The literature contains cases of moles that darkened, grew or changed, and cases of melanoma in users, which has prompted regulatory-agency warnings. Any new or changing mole in that context requires dermatological evaluation.

Is Melanotan II approved in any country?

No. Its clinical development was abandoned. The α-MSH analog that was approved is afamelanotide (Scenesse), a different linear peptide indicated only for erythropoietic protoporphyria. Melanotan II is a research compound worldwide.

What does it mean that Melanotan II is “non-selective”?

That it activates several melanocortin receptors at once: MC1R in the skin and MC3R/MC4R in the brain. That is why its observed effects span pigmentation, reduced appetite, erections and nausea. Later analogs (PT-141, afamelanotide) were designed to keep only one of those receptors.

Related reading: Melanotan II: Melanocortin Agonist · PT-141 (Bremelanotide): A Melanocortin Receptor Agonist

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty